http://orcid.org/0000-0002-4789-9258
Figures
Abstract
Background
Mass drug administration (MDA), targeted at school-aged children (SAC) is the method recommended by the World Health Organization for the control of morbidity induced by soil-transmitted helminth (STH) infection in endemic countries. However, MDA does not prevent reinfection between treatment rounds and research suggests that only treating SAC will not be sufficient to bring prevalence to low levels and possibly interrupt transmission of STH. In countries with endemic infection, such as Myanmar, the coverage, who is targeted, and rates of reinfection will determine how effective MDA is in suppressing transmission in the long-term.
Methods/principal findings
In this paper, data from an epidemiological study on STH, comprising three surveys conducted between June 2015 and June 2016 in the delta region of Myanmar, are analysed to determine how STH prevalence and intensity in the study community changes over the course of a year, including reinfection after two MDA rounds in which the whole study sample (all age groups, n = 523) were treated with albendazole. Prevalence in the first survey (August 2015) was 27.92% for any STH, 5.54% for Ascaris lumbricoides, 17.02% for Trichuris trichiura and 9.75% for hookworm. Over the year (survey one to survey three), prevalence of any STH decreased by 8.99% (P < 0.001) and mean EPG significantly decreased for T. trichiura (P < 0.01) and hookworm (P < 0.001). Risk ratios (RRs) for a four-month reinfection period (August to December) were statistically significant and were below one, indicating that STH prevalence had not bounced back to the prevalence levels recorded immediately prior to the last round of treatment (any STH RR = 0.67, 95% CI 0.56–0.81; A. lumbricoides RR = 0.31, 95% CI 0.16–0.59; T. trichiura RR = 0.70, 95% CI 0.55–0.88; hookworm RR = 0.69, 95% CI 0.50–0.95). The only statistically significant RR for the six-month reinfection period (December to June) was for A. lumbricoides infection in SAC (RR = 2.67, 95% CI 1.37–5.21). All six-month RRs were significantly higher than four-month RRs (P < 0.05). Evidence of predisposition to infection (low and high), as measured by the Kendall Tau-b statistic, was found for all species overall and within most age groups stratifications, except for hookworm infection in preschool-aged children.
Conclusions/significance
This study demonstrates that, for certain demographic groups, a six-month gap between MDA in these communities is enough time for STH infection to return to STH prevalence levels recorded immediately before the previous MDA round, and that on average the same individuals are being consistently infected between MDA rounds.
Author summary
Mass drug administration (MDA), treating either whole communities or targeted groups without a prior diagnosis, is used as a control strategy for many neglected tropical diseases, including soil-transmitted helminth (STH) infection. MDA takes place at set intervals, aiming to reduce morbidity caused by the target disease. Research and policy focus is also increasingly considering the potential of interrupting STH transmission, leading to elimination. In this study we measure STH infection in two villages in the delta region of Myanmar over the course of a year, both before and after MDA rounds, to quantify the effect of treatment on infection and to identify groups with persistent infections. We found that whilst overall prevalence of STH infection decreased over the year, intensity of infection, measured by eggs per gram of faeces, did not significantly decrease. We also found evidence to suggest that particular people are predisposed to STH infection. This is possibly due to non-compliance to MDA, or behavioural and social factors. The findings presented here will provide evidence to support continuing Myanmar’s MDA programme for STH control and using accurate diagnostics to identify and target “predisposed” people for sustained treatment.
Citation: Dunn JC, Bettis AA, Wyine NY, Lwin AMM, Tun A, Maung NS, et al. (2019) Soil-transmitted helminth reinfection four and six months after mass drug administration: results from the delta region of Myanmar. PLoS Negl Trop Dis 13(2): e0006591. https://doi.org/10.1371/journal.pntd.0006591
Editor: Susana Vaz Nery, University of New South Wales Faculty of Medicine, AUSTRALIA
Received: June 4, 2018; Accepted: January 24, 2019; Published: February 15, 2019
Copyright: © 2019 Dunn et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information Files.
Funding: JCD, AAB and NYW are supported by the London Centre for Neglected Tropical Disease Research (LCNTDR), funded by GlaxoSmithKline. RMA is supported by the Bill and Melinda Gates Foundation (#OPP1053230). The funders had not role in study design, data analysis, decision to publish or preparation of the manuscript.
Competing interests: Roy M Anderson is a non-executive board member of GlaxoSmithKline (GSK). GSK played no role in study design, data analysis, decision to publish or preparation of the manuscript. All other authors declare no competing interests.
Introduction
Soil-transmitted helminth infections (STHs) are classified by the World Health Organization (WHO) as neglected tropical diseases (NTDs). Approximately 1.4 billion people worldwide are estimated to be infected with at least one of the main STHs (Ascaris lumbricoides, Trichuris trichiura, Ancylostoma duodenale, Necator americanus) [1]. Endemic countries carry out mass drug administration (MDA) campaigns to control STH infections with the goals of reducing STH prevalence and intensity of infection to a level where there is a low risk of morbidity in children [2,3]. The WHO recommends that MDA is carried out annually or biannually, targeting school-aged children (SAC, 5–14 years old) as they are at the highest risk of morbidity [3,4]. A goal set by the WHO for STH control is to decrease the prevalence of medium and high intensity infections (MHII) in SAC to below 1% at which point STH morbidity has been eliminated as a public health problem in the area [2]. In 2017, this guideline was updated to include treatment of young children (12 to 23 months old), preschool-aged children (pre-SAC, 2–4 year olds), adolescent girls (10–19 year olds) and women of reproductive age (WRA, 15–45 year olds) [3]. Whilst MDA that targets pre-SAC and SAC can reduce morbidity in these groups, research indicates that MDA targeting all age groups (community-wide) is more effective at reducing STH prevalence and intensity in all groups, especially in hookworm-endemic areas [5,6], and to interrupt transmission [7–9].
Myanmar, in Southeast Asia, is endemic for STH. A WHO-led survey conducted in 2002–2003 found that 69.7% of the SAC sampled were infected with at least one STH (A. lumbricoides = 48.5%, T. trichiura = 57.5% and hookworm = 6.5%) and 18.2% of SAC had a medium/high intensity infection [10]. MDA programmes targeting STH and lymphatic filariasis (LF) have been conducted in Myanmar since 2003. The LF MDA programme is conducted under the Global Programme to Eliminate Lymphatic Filariasis (GPELF) and treats all age groups annually with albendazole and diethylcarbamazine (DEC) in December or January [11]. The STH MDA programme treats pre-SAC and 5–9 year olds (primary school children) annually, eight months after GPELF (August), with albendazole. A follow-up WHO survey, conducted in 2012, found that, after seven years of MDA, STH prevalence in SAC had decreased to 20.9% [12]. Coverage of the STH programme has been consistently high since 2006, national coverage of SAC was reported as 97.49% in 2016 [12,13]. There are few recent epidemiological studies on STH in Myanmar. In 2015, Htoon et al. reported 18.6% prevalence of T. trichiura in urban 6–8 year olds [14].
Anthelminthic drugs kill helminths within hosts, but do not prevent reinfection between MDA rounds [15,16]. Research into drug efficacy also suggests that a single dose of albendazole, as given in most countries’ MDA programmes, will not clear intestinal helminths, especially T. trichiura infections [17–20]. Therefore, as well as individuals gaining new infections after MDA, they may also be harbouring old infections not killed by previous treatment. Reinfection, or the change in STH prevalence and intensity over time, depends on multiple factors: the efficacy of the anthelminthics and coverage of MDA to effectively clear STH infections from all infected individuals in the population, the level of environmental contamination with eggs and larvae and an individual’s exposure to environmental contamination (behavioural and social factors) [21].
Those who are consistently reinfected with STH after clearing their infections with treatment are considered to be “predisposed” to infection [22]. Research is ongoing to determine what the underlying factors of predisposition are. They are likely to be a combination of genetic, immunological, environmental and behavioural factors [23–25]. Predisposition is usually defined as individuals who consistently reacquire infection to the same intensity class of infection (i.e. low, medium, high) as prior to treatment [26]. However, in low STH intensity populations, such as those that have undergone multiple years of MDA, the definition of predisposition could be widened to include all those who consistently harbour STH infections between MDA rounds. Being able to prioritise the groups of people that are consistently infected, despite MDA, would be highly beneficial to STH control programmes that are in the final years of MDA and are targeting the interruption of transmission [9,27]. A change in treatment policy may be desirable to target those predisposed to infection if they can easily be identified.
In this paper we describe and analyse the infection status of study participants in a longitudinal epidemiological study of STH in Myanmar that was conducted between June 2015 and June 2016. The aim of this analysis is to determine how the prevalence and intensity of STH infection changes over the course of a year under the influence of the STH and LF MDA programmes in Myanmar, both of which aim to significantly reduce STH prevalence and intensity (although this is a secondary aim for the LF MDA programme). We also investigate if there is evidence for predisposition to infection in the study sample when stratified by a variety of confounding variables including age and sex.
Methods
Ethics statement
Data were collected in an STH epidemiological study that has been detailed in a previous publication [28]. The study received ethical approval from the Imperial College Research Ethics Committee, Imperial College London, UK (ICREC– 15IC2667) and the Department of Medical Research Ethics Review Committee, Ministry of Health and Sports, Myanmar. The study was explained to each potential participant and consent was sought at this time. Adults (18 years and above) provided consent for themselves and for any children (under 18 years old) under their care (parents or guardians). Children aged 10–17 years old also signed assent forms. All participants in the study were offered anthelminthics regardless of their disease status and non-participants in the study were treated as usual by the governmental MDA programmes (Fig 1). Treatment was instructed to be directly observed, although this could not be guaranteed in all cases. All participants provided their own answers to questionnaires except children from 2–4 years old, for whom we received answers from a parent/guardian.
ALB = albendazole, DEC = diethylcarbamazine citrate, GPELF = Global Programme to Eliminate Lymphatic Filariasis, LF = lymphatic filariasis, MDA = mass drug administration, STH = soil-transmitted helminths. Adapted with permission from the supplementary information of Dunn et al. (2017) [28].
Study sites and design
Data collection took place between June 2015 and June 2016 in Udo village, Taikkyi township, Yangon Region and Kyee Kan Theik village, Nyaung Don township, Ayeyarwaddy Region. Further details on the study sites, including environmental and socioeconomic information, are provided in a previous publication [28]. In June 2015, a demographic survey and census were completed in the two study villages. Participants that fulfilled the inclusion criteria (permanent residents of the village, provided informed written consent, above two years old, not pregnant/breastfeeding) were recruited for the study by random selection of households. For each randomly selected household, the number of eligible household residents were tallied, and selection of households continued until the required sample size had been reached. Participants completed questionnaires collecting data on participants’ socioeconomic status, household structure and access to water, sanitation and hygiene (WaSH) facilities. The study comprised three parasitology surveys in August 2015 (first survey–S1), December 2015 (second survey–S2) and June 2016 (third survey–S3) (Fig 1). Stool samples were collected from the participants in each parasitology survey and were assessed for STH infection by trained laboratory technicians using the Kato-Katz method [29]. Egg counts were multiplied by 24 to give eggs per gram of faeces (EPG) [30]. The participants and their stool samples were assigned unique identification (ID) codes to maintain confidentiality and to link results over all surveys. All study participants were treated with 400mg albendazole at each survey and were also treated with 6mg/kg DEC at S2. Since the study included participants from all age groups above two years old, this meant that participants over the age of nine years received two additional albendazole treatments (in S1 and S3) compared to the regular treatment schedule (Fig 1).
Data
Data for the following analyses were from all participants who had a recorded Kato-Katz result from all three surveys. Overall, 523 participants (53.5% of total recruited participants, 19.0% of village populations) from 211 households (67.6% of total recruited households, 35.6% of total households in the villages) had Kato-Katz data from all three surveys (S1 Fig). Table 1 presents the age and sex breakdown of the study participants. Data from both villages were merged and analysed as one dataset.
Statistical analysis
RStudio (R version 3.0.1, Vienna, Austria) was used for the following statistical analyses and to create the figures. Participants were grouped into age groups as defined by the WHO: preschool-aged children (pre-SAC) are 2–4 year olds, school-aged children (SAC) are 5–14 year olds and adults are 15+ year olds [4]. Exact confidence intervals (95% two-sided) for mean prevalence were calculated using the Clopper-Pearson method [31]. Non-parametric mean EPG adjusted percentiles (95% two-sided, bias-corrected and accelerated—BCa) were calculated using bootstrapping methodology with the “boot” package. Risk ratios (RRs) were calculated by dividing the prevalence of infection in the later survey by the prevalence of infection in the earlier survey (e.g. RR = prevalence of A. lumbricoides in S2 / prevalence of A. lumbricoides in S1). RR confidence intervals were calculated by multiplying the standard error of the natural logarithm of the RR by the z-score, and adding or subtracting the value from the log RR [32]. The significance test for the differences between RRs was derived from a formula published by Altman and Bland, 2003 [33]. The WHO recommended intensity cut-offs were used to group individual EPG into low, medium and high intensity infections [2]. We used McNemar’s test to assess the differences in prevalence and Wilcoxon signed rank test to assess the differences in intensity over the surveys, the significance level was set at P ≤ 0.05. We used the Kendall rank correlation coefficient test to analyse the correlation between egg counts in different surveys, indirectly assessing predisposition to infection. The Kendall Tau-b value was chosen as it adjusts for tied ranks and the significance level set at P ≤ 0.05. Data from all participants were included in Kendall-Tau analysis, including those who were uninfected in multiple surveys. Kendall Tau-b values range between minus one (all pairs are discordant) and one (all pairs are concordant), a higher Tau-b value indicates more concordant than discordant pairs of individual egg counts and therefore higher overall correlation [34].
The study took place over the course of a year. Therefore, all participants will have aged one year during the study. Whilst there is a well-established relationship between age and STH infection, for simplicity we maintained the recorded ages for all participants at the age recorded in the first survey. This is assuming that age-related exposure did not drastically change over the course of a year. Also, we have maintained the usual WHO definition of SAC (5–14 years old), despite the fact that there is a different treatment frequency for 5–9 and 10–14 year olds in Myanmar. We have done this to align with how the WHO expects STH outcomes to be reported regarding infection prevalence and intensity by age grouping. We cannot guarantee that all infections were cleared after MDA. Therefore, “reinfection” in the case of our analysis does not necessarily refer to new infections picked up between MDA rounds, but rather changes in the number and proportion of infections between surveys.
Results
Reinfection–prevalence
Baseline (S1) prevalence was 27.92% for any STH, 5.54% for A. lumbricoides, 17.02% for T. trichiura and 9.75% for hookworm (Table 2). From S1 to S2 prevalence of any STH fell by 8.99% and the reduction was statistically significant (P < 0.001), there was no change in prevalence from S1 to S2 (not statistically significant) and therefore the change in prevalence over the study year (S1 to S3) was also significant (P < 0.001). The reductions in prevalence of each STH separately, were statistically significant from S1 to S2 and from S1 to S3 (P < 0.05). There were no statistically significant changes in prevalence from S2 to S3. In the final survey (S3), prevalence of infection with any STH was 28.07% in SAC.
Risk ratios (RRs) for reinfection differed between STH species and reinfection period (Fig 2 and S1 Table). Four months post-MDA, the risk of infection was lower than in the preceding survey for all STHs (any STH RR = 0.67, 95% CI 0.56–0.81; A. lumbricoides RR = 0.31, 95% CI 0.16–0.59; T. trichiura RR = 0.70, 95% CI 0.55–0.88; hookworm RR = 0.69, 95% CI 0.50–0.95). The only statistically significant six-month RR was for A. lumbricoides infection in SAC (RR = 2.67, 95% CI 1.37–5.21). However, the six-month RRs were significantly higher than the four-month RRs for infection with all STH species (P < 0.05) except hookworm (P = 0.44). Six-month RRs were also statistically significantly higher than four-month RRs in SAC for infection with any STH, A. lumbricoides and T. trichiura, but were significantly lower for hookworm (P < 0.05). Six-month RRs were significantly higher in males for any STH and T. trichiura (P < 0.01) but higher in females for A. lumbricoides (P < 0.001).
Blue = 4 months reinfection (survey 1 to survey 2). Red = 6 months reinfection (survey 2 to survey 3). * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001 –black asterisks represent statistical significance of each risk ratio, green asterisks represent statistical difference between risk ratios for each group. Horizontal lines represent 95% confidence intervals. Pre-SAC = preschool-aged children (2–4 years old), SAC = school-aged children (5–14 years old), Adult = 15+ years old. No Ascaris lumbricoides infections were found in pre-SAC for all surveys, therefore no points are presented.
From S1 to S2, 86.2% of A. lumbricoides infections, 52.8% of T. trichiura infections and 66.7% of hookworm infections were “cured” (Table 3). This decreased to 44.4% for A. lumbricoides, 50.0% for T. trichiura and 62.9% for hookworm infections from S2 to S3. Whereas, from S1 to S2, 1.0%, 4.6% and 3.8% of previously uninfected people became infected with A. lumbricoides, T. trichiura and hookworm infections, respectively. From S2 to S3, 1.6%, 6.7% and 3.3% of previously uninfected people became infected with A. lumbricoides, T. trichiura and hookworm infections, respectively.
Reinfection–intensity
Mean EPG significantly decreased for A. lumbricoides (P < 0.01) and T. trichiura (P < 0.0001) from S1 to S2, and significantly increased for hookworm (P < 0.01). No changes in EPG from S2 to S3 were statistically significant. Over the year (S1 to S3), mean EPG significantly decreased for T. trichiura (P < 0.01) and hookworm (P < 0.001). The increase in A. lumbricoides EPG was not statistically significant (Table 2). A majority of the STH infections in all three surveys were low intensity infections for T. trichiura and hookworm (88.7–93.5% and 97.1–100%, respectively), whereas the majority of A. lumbricoides infections were low intensity in S2 (55.6%) and medium intensity in S1 (51.7%) and S3 (53.8%). At the final survey (S3) there were no medium/high intensity hookworm infection in SAC but 6.14% and 5.26% A. lumbricoides and T. trichiura infections, respectively. Therefore, the WHO target of less than 1% MHII in SAC has not been achieved in the study villages.
When mean EPG change was stratified by age group (Fig 3 and S2 Table) mean A. lumbricoides and T. trichiura EPG decreased from S1 to S2 and increased from S2 to S3 for all age groups except the 25–39 year olds for A. lumbricoides for which the opposite occurred. The mean change in EPG was not homogenous between all age groups. There was minimal change in mean EPG for both A. lumbricoides and T. trichiura in the youngest and oldest age groups. For hookworm, the increase and decrease in mean EPG was driven by the change in 5–14 year olds. A particularly high hookworm EPG result in the SAC group (158,136 EPG) for S2 may have skewed these results upwards.
Blue bars = 4 months reinfection (survey 1 to survey 2). Red bars = 6 months reinfection (survey 2 to survey 3). Vertical lines represent 95% confidence intervals.
Predisposition to STH infection (consistent infection)
A total of 38 (7.27%) participants had STH infections in all three surveys and 67 (12.81%) had infections for any two of the three surveys. Correlation coefficients (Kendall Tau-b) of individual participants’ egg count results between surveys were statistically significant for all species of STH (Table 4). Most of the correlations remained significant when stratified by sex or age group. Trichuris trichiura egg counts had the strongest concordance between surveys especially for males, SAC and pre-SAC. The strongest concordance was for hookworm egg counts in pre-SAC between the first and second surveys. However, the Kendall’s Tau-b value may have been inflated due to the small number of pre-SAC infected with hookworm (two in survey one, three in survey two). Non-significant and low Tau values were calculated for A. lumbricoides infection in males and hookworm infection in SAC, denoting little evidence for predisposition in these groups.
Discussion
MDA programmes have been ongoing in the delta region of since 2003 for STH, and since 2013 for LF [10,12]. Whilst STH prevalence has dropped significantly since the initiation of MDA, the prevalence target set by WHO to discontinue MDA (under 1%) has not yet been reached in surveyed communities [14,28]. Currently, there is no monitoring and evaluation (M&E) of STH in Myanmar and no longitudinal studies have taken place since 1990 [35]. It is therefore important for longitudinal M&E studies to take place in the country so that the long-term impact of MDA can be evaluated. The results of this study show that overall STH prevalence was significantly reduced following two community-wide MDA rounds of the study sample (27.92 to 18.93%), and the intensities of infection (measured by EPG) of T. trichiura and hookworm were significantly reduced (73.56 to 41.07 EPG and 40.2 to 11.47 EPG, respectively). However, in the final survey, prevalence of STH was 28.07% in SAC, indicating that, according to the WHO guidelines, MDA should continue at the current frequency [4].
In this analysis, risk ratios were used to describe the patterns of infection over a four-month and six-month reinfection period. RRs for the six-month reinfection period were significantly higher than for the four-month reinfection period. This is not surprising since the extra two months allows more time for people to become newly infected and for surviving infections to re-establish. If we assume that the MDA rounds had cleared infection, then the data suggest that, in the study setting, four months is not enough time for STH to re-infect individuals to the prevalence levels pertaining before that particular round of treatment, but six months may be enough time. However, it is more likely that, due to sub-100% drug efficacy plus non-compliance to treatment, some infections were retained after MDA, and six months was enough time for the surviving helminths to release sufficient eggs to trigger the acquisition of new A. lumbricoides infections in SAC. Due to the low efficacy of albendazole against T. trichiura (as low as 30.7% and 43.6% cure rate in meta-analyses by Moser et al. [36] and Keiser et al. [17], respectively), it is possible that there was a greater magnitude of reestablishment of surviving worms for this species as proportionally fewer T. trichiura worms will have been affected by the initial treatment and thus more T. trichiura worms will have survived to reproduce. In the study sites included in this analysis, T. trichiura is the most prevalent STH in all age groups (peak of 29.82% in SAC, S1). Whilst shortening the time between MDA rounds may limit reestablishment of all STH species, if a single dose of albendazole is the treatment strategy in STH MDA programmes, the prevalence of T. trichiura will not be adequately reduced [37,38]. Research is ongoing into the efficacy of co-administrations with anthelminthics such as moxidectin, ivermectin or tribendimidine to target T. trichiura [39–41]. Helminth eggs are highly durable in the right environmental conditions. A. lumbricoides and T. trichiura eggs can remain viable and infective for several months [42], so individuals can become reinfected from eggs persisting in the environment, without the need for the deposition of new infective stages [16,43]. There is also the possibility of a seasonal effect on transmission [44,45]. The first and third surveys both took place during the dry season, whereas the second survey took place during the rainy season. Infective stage survival is known to be increased during rainy seasons [46–48]. It should also be noted that, for logistical reasons, the third survey in this study (June 2016) took place two months prior to the usual timing of the STH MDA round (August) (Fig 1). During the annual August MDA round, only children aged 2–9 years old are treated. As such, all 2–9 year olds not enrolled in the study will have had a further two months for reinfection and all other age groups not enrolled in the study will have a further six or seven months until the community-wide lymphatic filariasis (LF) MDA round (through GPELF). Therefore, we can hypothesise that if six months is enough time for STH prevalence to re-establish to the levels immediately prior to the last MDA round, the eight months between treatments for SAC and the 12 months between treatments for all other age groups may also allow infection to fully re-establish.
Prevalence is used as a key STH epidemiological metric, but intensity of infection is more important as a determinant of morbidity [2]. Whilst STH prevalence dropped significantly between the first and third surveys, the slight reductions in mean T. trichiura and hookworm EPG were not statistically significant. STH intensity at the beginning of the study was already at a very low level. Most participants infected with STH had low intensity infections. However, at S3 6.14% of SAC had MHII of A. lumbricoides and 5.26% with T. trichiura. The WHO target is to decrease MHII in SAC to below 1%, thereby indicating that STH in that country has been eliminated as a public health problem [2]. Unfortunately, this has not yet been achieved in the study villages. Prior work on the effect of long-term MDA programmes on STH have identified that substantial drops in STH prevalence and intensity in the first years of MDA may be followed by smaller reductions in subsequent years [49,50]. For example, an eight year MDA programme in Burundi reported significant drops in prevalence in the first four years and no further decrease in the last four years [50]. A monitoring survey in Kenya found that the largest reductions in A. lumbricoides and hookworm prevalence and intensity were recorded after the first MDA in comparison to the second MDA and whilst prevalence of T. trichiura was significantly reduced after three years of MDA, the proportion of medium to high T. trichiura infections was not [51]. The reasons for this may well be related to MDA coverage levels and individual compliance to treatment at multiple rounds of treatment [52]. Few studies to date have recorded individual compliance to treatment but persistent low prevalence may, in part, be due to persistent non-compliers to treatment [53]. The possibility of emerging resistance against anthelminthics should also continue to be considered and monitored, especially in mass treatment programmes that have been ongoing for an extended period of time [54,55].
Evidence of predisposition to STH infection has been found in several epidemiological studies [22,56,57] and the results of the Kendall’s Tau-b analysis indicates that predisposition to infection exists within the study sample. Concordance between egg counts indicates that the same individuals have reinfected with STH after treatment. Stronger concordance between survey egg counts, and therefore stronger evidence for predisposition, was found in males and the younger age groups for T. trichiura and hookworm infection but only in females for A. lumbricoides infection. This is in agreement with Holland et al. [58], who found stronger evidence for A. lumbricoides predisposition in females, but in disagreement with Haswell-Elkins et al. [59] and Quinnell et al. [60], with females more predisposed to hookworm infection. Whilst identifying individual people that are predisposed to infection would be costly and time-consuming, requiring diagnosis at several time points, building and collating evidence on groups of people (e.g. based on sex, age or occupation) that are predisposed to infection would allow them to be prioritised in MDA programmes when possibly targeting transmission interruption [61,62]. The reasons that underlie predisposition to infection (genetic, immunological, behavioural or exposure-related) are difficult to separate and quantify in epidemiological studies. The “susceptibility” factors of predisposition (genetics and immunology) are unlikely to change with public health interventions, but the “exposure” factors can be reduced through health education and WaSH initiatives.
A limitation of this study related to the data collection study is the low sensitivity of the Kato-Katz technique as a diagnostic tool. It is highly possible that infections were missed due to its use [63]. Another limitation is that, for important ethical reasons, the whole study sample (all ages) had to be treated during the MDA rounds that immediately followed the surveys, instead of the usual targeted ages (SAC only after the first and third surveys). The patterns of reinfection presented here therefore do not necessarily represent the patterns that will have occurred in previous years, during routine MDA. As we could not confirm clearance of infection after MDA, the results may not be viewed as true “reinfection”. However, the aim of individual treatment during MDA programmes is not to clear infection in hosts but to reduce the intensity of infection and subsequent morbidity [4,64]. Therefore, the “reinfection” we measure in this study is synonymous with the reinfection that is occurring between treatments in most endemic country MDA programmes. During data collection we attempted to ensure that treatment was taken via directly-observed therapy (DOT) where possible, but without data to confirm that infections were cleared we cannot assume this was always the case. Finally, this analysis focuses on the individuals that were present for all three surveys during the epidemiological study. It is possible that these individuals may have systematically different behaviour to those that dropped out or were lost to follow-up.
The key epidemiological observation in this study is the persistence of infection despite frequent and community wide MDA (through the STH MDA programme and GPELF), and the strong evidence for predisposition. Whilst the majority of infections were low intensity, the target of below 1% MHII in SAC has not been achieved and community-wide prevalence of STH at the end of the study was 18.93%. The prevalence of any STH in SAC at the end of the study (S3) was 28.07% which exceeds the threshold that WHO recommends for stopping MDA against STH [4]. Another key finding, from risk ratio analysis, is that a six-month gap between MDA rounds may be sufficient for STH infection to re-establish to pre-treatment levels within the community. In the long term, if diagnosis can be made more precise with new tools such as qPCR, and the costs of such tests greatly reduced, then future STH control may need to be based on targeted treatment to those predisposed to infection in order to eliminate transmission [65,66].
Supporting information
S1 Table. Risk ratios of STH infection between surveys.
https://doi.org/10.1371/journal.pntd.0006591.s002
(XLSX)
S2 Table. Mean change in eggs per gram of faeces (EPG) between surveys.
https://doi.org/10.1371/journal.pntd.0006591.s003
(XLSX)
Acknowledgments
We thank the Myanmar Ministry of Health and Sports for their continued support and advice. We thank Tom Churcher, Maria-Gloria Basáñez and Rachel Pullan for their comments on earlier drafts of this manuscript. We thank James Truscott for advice concerning data analysis and visualisation.
References
- 1. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasites and Vectors. 2014;7(1).
- 2.
WHO. Eliminating soil-transmitted helminthiases as a public health problem in children: progress report 2001–2010 and strategic plan 2011–2020. Geneva, Switzerland: World Health Organization; 2012.
- 3.
WHO. Guideline: Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups [Internet]. WHO. Geneva: World Health Organization; 2017.
- 4.
WHO. Helminth control in school-age children—Second Edition [Internet]. Geneva, Switzerland: World Health Organization; 2012.
- 5. Farrell SH, Coffeng LE, Truscott JE, Werkman M, Toor J, de Vlas SJ, et al. Investigating the effectiveness of current and modified World Health Organization guidelines for the control of soil-transmitted helminth infections. Clin Infect Dis. 2018 Jun 1;66(suppl_4):S253–9. pmid:29860285
- 6. Clarke NE, Clements ACA, Doi SA, Wang D, Campbell SJ, Gray D, et al. Differential effect of mass deworming and targeted deworming for soil-transmitted helminth control in children: a systematic review and meta-analysis. Lancet. 2016;
- 7. Truscott JE, Werkman M, Wright JE, Farrell SH, Sarkar R, Ásbjörnsdóttir K, et al. Identifying optimal threshold statistics for elimination of hookworm using a stochastic simulation model. Parasit Vectors. 2017;10.
- 8. Anderson R, Truscott J, Hollingsworth TD. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths. Philos Trans R Soc. 2014;369.
- 9. Truscott JE, Hollingsworth TD, Brooker SJ, Anderson RM. Can chemotherapy alone eliminate the transmission of soil transmitted helminths. Parasit Vectors. 2014;7(1):266.
- 10. Montresor A, Zin TT, Padmasiri E, Allen H, Savioli L. Soil-transmitted helminthiasis in Myanmar and approximate costs for countrywide control. Trop Med Int Heal. 2004;9(9):1012–5.
- 11. Win KM, Tripathy JP, Maung TM, Oo T, Thi A, Lon KN, et al. Rapid progress towards elimination of lymphatic filariasis in endemic regions of Myanmar as a result of 16 years of anti-filarial activities (2001–2016). Trop Med Health. 2018 Dec 16;46(1):14.
- 12. Tun A, Myat SM, Gabrielli AF, Montresor A. Control of soil-transmitted helminthiasis in Myanmar: results of 7 years of deworming. Trop Med Int Heal. 2013;18(8):1017–20.
- 13.
WHO. PCT databank: soil-transmitted helminthiases [Internet]. Geneva, Switzerland: World Health Organization; 2017 [cited 2017 Jan 4]. Available from: http://www.who.int/neglected_diseases/preventive_chemotherapy/sth/en/
- 14. Htoon TT, Tun T, Oo KY, Thein W, Tin HH, Chai J-Y, et al. Status of infection with soil-transmitted helminths among primary school children in three selected townships of Yangon Division. Myanmar Heal Sci Res J. 2015;27(3).
- 15. Utzinger J, Raso G, Brooker S, De Savigny D, Tanner M, Ørnbjerg N, et al. Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasitology. 2009 Nov 11;136(13):1859. pmid:19906318
- 16. Ziegelbauer K, Speich B, Mäusezahl D, Bos R, Keiser J, Utzinger J, et al. Effect of Sanitation on Soil-Transmitted Helminth Infection: Systematic Review and Meta-Analysis. PLoS Med. 2012 Jan 24;9(1):e1001162. pmid:22291577
- 17. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections. J Am Med Assoc. 2008;299(16):1937–48.
- 18. Belew S, Getachew M, Suleman S, Mohammed T, Deti H, D’Hondt M, et al. Assessment of efficacy and quality of two albendazole brands commonly used against soil-transmitted helminth infections in school children in Jimma Town, Ethiopia. PLoS Negl Trop Dis. 2015;9(9).
- 19. Sinniah B, Chew PI, Subramaniam K. A comparative trial of albendazole, mebendazole, pyrantel pamoate and oxantel pyrantel pamoate against soil-transmitted helminthiases in school children. Trop Biomed. 1990;7(2):129–34.
- 20. Stephenson LS, Latham MC, Kinoti SN, Kurz KM, Brighall H. Improvements in physical fitness of Kenyan schoolboys infected with hookworm, Trichuris trichiura and Ascaris lumbricoides following a single dose of albendazole. Trans R Soc Trop Med Hyg. 1990;84:277–82. pmid:2389321
- 21. Cundill B, Alexander N, Bethony JM, Diemert D, Pullan RL, Brooker S. Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community. Parasitology. 2011;138(11):1406–16. pmid:21819640
- 22. Schad GA, Anderson RM. Predisposition to hookworm infection in humans. Science. 1985 Jun;228(4707):1537–40. pmid:4012307
- 23. Mangano VD, Modiano D. Host genetics and parasitic infections. Clin Microbiol Infect. 2014 Dec;20(12):1265–75. pmid:25273270
- 24. Saltykova IV, Freydin MB, Ogorodova LM, Puzyrev VP. Genetic predisposition to helminthiases. Russ J Genet Appl Res. 2014;4(5):405–15.
- 25. Holland CV. Predisposition to ascariasis: patterns, mechanisms and implications. Parasitology. 2009 Oct;136(12):1537–47. pmid:19450374
- 26. Walker M, Hall A, Basáñez MG. Individual predisposition, household clustering and risk factors for human infection with Ascaris lumbricoides: New epidemiological insights. PLoS Negl Trop Dis. 2011;5(4).
- 27. Anderson R, Farrell S, Turner H, Walson J, Donnelly CA, Truscott J. Assessing the interruption of the transmission of human helminths with mass drug administration alone: optimizing the design of cluster randomized trials. Parasit Vectors. 2017;10(93).
- 28. Dunn JC, Bettis AA, Wyine NY, Lwin AMM, Lwin ST, Su KK, et al. A cross-sectional survey of soil-transmitted helminthiases in two Myanmar villages receiving mass drug administration: epidemiology of infection with a focus on adults. Parasit Vectors. 2017;10(374).
- 29. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo. 1972;14(6):397. pmid:4675644
- 30.
WHO. Bench aids for the diagnosis of intestinal parasites. Geneva, Switzerland; 1994.
- 31. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17:857–72. pmid:9595616
- 32. Kirkwood BR, Sterne JAC, Kirkwood BR. Essential medical statistics. Blackwell Science; 2003. 501 p.
- 33. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003 Jan 25;326(7382):219. pmid:12543843
- 34. Ng SK, Holden L, Sun J. Identifying comorbidity patterns of health conditions via cluster analysis of pairwise concordance statistics. Stat Med. 2012 Nov 30;31(27):3393–405. pmid:22714868
- 35. Hlaing T, Saw T, Kyin M-L. Control of ascariasis through age-targeted chemotherapy: Impact of 6-monthly chemotherapeutic regimens. Bull World Health Organ. 1990;68(6):747–53. pmid:2150011
- 36. Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis. BMJ. 2017 Sep 25;358:j4307. pmid:28947636
- 37. Schulz JD, Moser W, Hürlimann E, Keiser J. Preventive Chemotherapy in the Fight against Soil-Transmitted Helminthiasis: Achievements and Limitations. Trends Parasitol. 2018 Jul 1;34(7):590–602. pmid:29858018
- 38. Palmeirim MS, Hürlimann E, Knopp S, Speich B, Belizario V, Joseph SA, et al. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis. Stolk WA, editor. PLoS Negl Trop Dis. 2018 Apr 27;12(4):e0006458. pmid:29702653
- 39. Barda B, Ame SM, Ali SM, Albonico M, Puchkov M, Huwyler J, et al. Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial. Lancet Infect Dis. 2018 Aug 1;18(8):864–73. pmid:29858149
- 40. Palmeirim MS, Hü Rlimann E, Knopp S, Speich B, Belizario V, Joseph SA, et al. Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis. PLoS Negl Trop Dis. 2018;12(4).
- 41. Bergquist R. Tribendimidine: great expectations. Lancet Infect Dis. 2016 Oct 1;16(10):1089–91. pmid:27472950
- 42. Brooker S, Clements AC, Bundy DA. Global epidemiology, ecology and control of soil-transmitted helminth infections. Adv Parasitol. 2006;62:221–61. pmid:16647972
- 43. Campbell SJ, Biritwum N-K, Woods G, Velleman Y, Fleming F, Stothard JR. Tailoring Water, Sanitation, and Hygiene (WASH) Targets for Soil-Transmitted Helminthiasis and Schistosomiasis Control. Trends Parasitol. 2017;1689.
- 44. Udonsi JK. Effectiveness of seasonal community-based mass-expulsion chemotherapy in the control of human hookworm infections in endemic communities. Public Health. 1985/09/01. 1985;99(5):295–301.
- 45. Davis EL, Danon L, Prada JM, Gunawardena SA, Truscott JE, Vlaminck J, et al. Seasonally timed treatment programs for Ascaris lumbricoides to increase impact—An investigation using mathematical models. PLoS Negl Trop Dis. 2018;12(1):e0006195. pmid:29346383
- 46. Horiuchi S, Paller VG V, Uga S. Soil contamination by parasite eggs in rural village in the Philippines. Trop Biomed. 2013;30(3):495–503. pmid:24189679
- 47. Schulz S, Kroeger A. Soil contamination with Ascaris lumbricoides eggs as an indicator of environmental hygiene in urban areas of north-east Brazil. J Trop Med Hyg. 1992 Apr;95(2):95–103. pmid:1560490
- 48.
Gunawardena GSA, Karunaweera ND, Ismail MM. Wet-days: are they better indicators of Ascaris infection levels? 2018;
- 49. Supali T, Djuardi Y, Bradley M, Noordin R, Ruckert P, Fischer PU, et al. Impact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern Indonesia. PLoS Negl Trop Dis. 2013/12/19. 2013;7(12):e2586. pmid:24349595
- 50. Ortu G, Assoum M, Wittmann U, Knowles S, Clements M, Ndayishimiye O, et al. The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi. Parasit Vectors. 2016 Dec 22;9(1):513. pmid:27660114
- 51. Okoyo C, Nikolay B, Kihara J, Simiyu E, Garn JV, Freeman MC, et al. Monitoring the impact of a national school based deworming programme on soil-transmitted helminths in Kenya: the first three years, 2012–2014. Parasit Vectors. 2016 Jul;9(1):408. pmid:27457129
- 52. Farrell S, Truscott J, Anderson RM. The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission. Parasit Vectors. 2017;
- 53. Shuford K V., Turner HC, Anderson RM. Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review. Parasit Vectors. 2016 Dec 27;9(1):29.
- 54. Albonico M, Engels D, Savioli L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int J Parasitol. 2004;34(11):1205–10. pmid:15491582
- 55. Vercruysse J, Albonico M, Behnke JM, Kotze AC, Prichard RK, McCarthy JS, et al. Is anthelmintic resistance a concern for the control of human soil-transmitted helminths? Int J Parasitol Drugs Drug Resist. 2011;1(1):14–27. pmid:24533260
- 56. Quinnell RJ, Pullan RL, Breitling LP, Geiger SM, Cundill B, Correa-Oliveira R, et al. Genetic and household determinants of predisposition to human hookworm infection in a Brazilian community. J Infect Dis. 2010;202(6):954–61. pmid:20681887
- 57. Forrester JE, Scott ME, Bundy DAP, Golden MHN. Predisposition of individuals and families in Mexico to heavy infection with Ascaris lumbricoides and Trichuris trichiura. Trans R Soc Trop Med Hyg. 1990;84(2):272–6. pmid:2389320
- 58. Holland CV, Asaolu SO, Crompton DW, Stoddart RC, Macdonald R, Torimiro SE. The epidemiology of Ascaris lumbricoides and other soil-transmitted helminths in primary school children from Ile-Ife, Nigeria. Parasitology. 1989 Oct;99 Pt 2(2):275–85.
- 59. Haswell-Elkins MR, Elkins DB, Manjula K, Michael E, Anderson RM. An investigation of hookworm infection and reinfection following mass anthelmintic treatment in the South Indian fishing community of Vairavankuppam. Parasitology. 1988;96(3):565–77.
- 60. Quinnell RJ, Slater AF, Tighe P, Walsh EA, Keymer AE, Pritchard DI. Reinfection with hookworm after chemotherapy in Papua New Guinea. Parasitology. 1993;106(4):379–85.
- 61. Anderson RM, Medley GF. Community control of helminth infections of man by mass and selective chemotherapy. Parasitology. 1985;90(04):629–60.
- 62. Farrell SH, Truscott JE, Anderson RM. The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission. Parasit Vectors. 2017 Dec 12;10(1):291. pmid:28606164
- 63. Easton AV, Oliveira RG, O’Connell EM, Kepha S, Mwandawiro CS, Njenga SM, et al. Multi-parallel qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans: field-based inferences on the impact of mass deworming. Parasit Vectors. 2016 Jan 27;9(1):38.
- 64.
WHO. Accelerated work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. WHO; 2012.
- 65. Easton AV., Oliveira RG, Walker M, O’Connell EM, Njenga SM, Mwandawiro CS, et al. Sources of variability in the measurement of Ascaris lumbricoides infection intensity by Kato-Katz and qPCR. Parasit Vectors. 2017 Dec 25;10:256. pmid:28545561
- 66. Mejia R, Vicuña Y, Broncano N, Sandoval C, Vaca M, Chico M, et al. A Novel, Multi-Parallel, Real-Time Polymerase Chain Reaction Approach for Eight Gastrointestinal Parasites Provides Improved Diagnostic Capabilities to Resource-Limited At-Risk Populations. Am J Trop Med Hyg. 2013;88(6):1041–7. pmid:23509117